Items Tagged ‘Andrew Limper’
September 20, 2019 · Leave a Comment
Good news about the effectiveness of antifibrotics for IPF
In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]
View full entry Comment on this
Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs